8.64 0.04 (0.47%)

New 52W Low today

2.0M XNAS Volume

XNAS 02 Apr, 2025 12:06 PM (EDT)

Viatris Inc Key Metrics

Default
All financials are in USD Million and price data in USD
VIEW MORE
Low Financial Strength
33.3 / 100
Mid Valuation
41.0 / 100
Technically Bearish
30.8 / 100
Weak Stock These stocks are the ones with poor quality and weak financial and technical aspects. However, these stocks have a medium valuation score. This indicates that investors should be highly watchful with these stocks. View Similar Embed DVM

Viatris Inc Live Price Chart

Switch to TradingView
Fetching data ...

Forecaster - Analyst Share Price Target and Estimates

Revenue forecast

Created with Highcharts 7.2.2Dec '22Dec '23Dec '24Dec '25Dec '2614k16k12k18kActual RevenueAvg. Estimate
Miss

Viatris Inc's Revenue was lower than average estimate 3 times in past 3 years

Consensus Recommendation

9 ANALYST Recommendations
HOLD

Created with Highcharts 7.2.21Sell5Hold1Buy2Strong Buy

The consensus recommendation from 9 analysts for Viatris Inc is HOLD

Forecaster is a Premium Feature
You need to upgrade your subscription plan to access this feature
See what you get

Viatris Inc Stock Analysis

Viatris Inc stock analysis with key metrics, changes, and trends.

Viatris Inc MetricVALUECHANGE %TRENDANALYSIS
Annual Revenue$14,739.3 M4.46%negative

Annual Revenue fell 4.46%, in the last year to $14,739.3 M. Its sector's average revenue growth for the last fiscal year was 7.47%.

Annual Net Profit$634.2 M1259.41%negative

Annual Net Profit fell 1,259.41% in the last year to $634.2 M. Its sector's average net profit growth for the last fiscal year was -32.28%.

Price to Earning Ratio-16.26-negative

Price to Earning Ratio is -16.26, which is negative.

Stock Price$8.64-27.64%negative

Stock Price fell 27.64% and underperformed its sector by 32.13% in the past year.

Quarterly Revenue$3,528.1 M8.06%negative

Quarterly Revenue fell 8.06% YoY to $3,528.1 M. Its sector's average revenue growth YoY for the quarter was 5.94%.

Quarterly Net profit$516.5 M32.54%positive

Quarterly Net profit rose 32.54% YoY to $516.5 M. Its sector's average net profit growth YoY for the quarter was -47.34%.

Debt to Equity Ratio0.77-positive

Debt to Equity Ratio of 0.77 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

Return on Equity(ROE)-3.24 %-3.24%negative

Return on Equity(ROE) for the last financial year was -3.24%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

Mutual Fund Holding63.47 %-1.55%negative

Mutual Fund Holding decreased by 1.55% in the last quarter to 63.47.

Promoter Share Holding0.73 %0.23%positive

Promoter Share Holding increased by 0.23% in the most recent quarter to 0.73%.

Interest Coverage Ratio-0.13-negative

Interest Coverage Ratio is -0.13, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

Institutional Holding83.39 %0%neutral

Institutional Holding remained the same in the last quarter at 83.39%.

VIEW LESS


Loading data..

Viatris Inc - Company Profile

What does Viatris Inc do?

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. Remaining 60% of sales is derived from its portfolio of legacy products which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

Viatris Inc Management structure

All Gross Remunerations are in USD
Mr. Scott A. Smith
Director and Chief Executive Officer
-
2024
Gross Remuneration
Year
Mr. Paul B. Campbell
Chief Accounting Officer and and Corporate Controller
-
2024
Gross Remuneration
Year
Ms. Theodora Mistras
Chief Financial Officer
-
2024
Gross Remuneration
Year

Viatris Inc Board of directors

All Gross Remunerations are in USD
Dr. Rogerio Vivaldi Coelho, M.B.A.,M.D.
Independent Director
-
2024
Gross Remuneration
Year
Ms. Elisha W. Finney
Independent Director
-
2024
Gross Remuneration
Year
Mr. Harry A. Korman
Independent Director
-
2024
Gross Remuneration
Year
Mr. James M. Kilts
Independent Director
-
2024
Gross Remuneration
Year
Mr. Rajiv Malik
Director
-
2024
Gross Remuneration
Year
Mr. Wyllie Don Cornwell
Independent Director
-
2024
Gross Remuneration
Year

Viatris Inc FAQ

How is Viatris Inc today?
Viatris Inc today is trading in the green, and is up by 0.47% at 8.64.
Viatris Inc is currently trading up 0.47% on an intraday basis. In the past week the stock fell -3.46%. stock has been down -31.21% in the past quarter and fell -27.64% in the past year. You can view this in the overview section.